Details for Patent: 11,571,398
✉ Email this page to a colleague
Which drugs does patent 11,571,398 protect, and when does it expire?
Patent 11,571,398 protects EMERPHED and is included in one NDA.
This patent has ten patent family members in nine countries.
Drugs Protected by US Patent 11,571,398
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexus | EMERPHED | ephedrine sulfate | SOLUTION;INTRAVENOUS | 213407-002 | Feb 28, 2023 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | USE OF EPHEDRINE SULFATE FOR TREATING HYPOTENSION | ⤷ Subscribe | ||||
| Nexus | EMERPHED | ephedrine sulfate | SOLUTION;INTRAVENOUS | 213407-001 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | USE OF EPHEDRINE SULFATE FOR TREATING HYPOTENSION | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,571,398
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2020276619 | ⤷ Subscribe | |||
| Canada | 3140043 | ⤷ Subscribe | |||
| China | 113825500 | ⤷ Subscribe | |||
| European Patent Office | 3968975 | ⤷ Subscribe | |||
| Israel | 288044 | ⤷ Subscribe | |||
| Japan | 2022532657 | ⤷ Subscribe | |||
| Japan | 2023091072 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
